Despite the advancements in innovation and usage of biomarkers in prostate cancer, there
exists tremendous potential in improving them to fulfil the unmet need that exists today …

Although prostate-specific antigen (PSA) remains the most used test to detect prostate
cancer (PCa), the limited specificity and an elevated rate of overdiagnosis are the main …

Along with significant advances in prostate cancer biology research, we also observe the
rapid development of modern diagnostic tests. New biomarkers are derived to detect …

Prostate Cancer Tissue-Based Biomarkers - StatPearls - NCBI Bookshelf US flag An official
website of the United States government Here's how you know NIH NLM Logo Access keys …

Although prostate cancer (PCa) is the most commonly diagnosed cancer in men, most
patients do not die from the disease. Prostate specific antigen (PSA), the most widely used …

Prostate cancer is the most frequently diagnosed malignancy in Indian men. The therapeutic
success rate for prostate cancer can be tremendously improved if the disease is diagnosed …

Prostate cancer is the most prevalent cancer in men and can be managed effectively if
diagnosed early and monitored. Currently, prostate-specific antigen testing in conjunction …

Significant technological advances in analytical methods and a greater understanding of
molecular carcinogenesis has paved the way toward a new era of disease detection. 1–3 …

BIOMARKERS for prostate cancer detection have never been more controversial. Recent
recommendations from the United States Preventive Task Force and revised American …

Prostate cancer (PCA) is a major health concern in current times. Ever since prostate
specific antigen (PSA) was introduced in clinical practice almost three decades ago, the …